Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis: Results from Greater Than 17,000 Patient-Years of Exposure

Overview of attention for article published in Dermatology and Therapy, November 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 54 Dimensions

Readers on

mendeley: 54 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 2,400 followers.

RT @Candida_papers: Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis: Results from Grea…

22 Nov 2019

Reply Repost Favourite

Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis: Results from Greater Than 17,000 Patient-Years of Exposure. https://t.co/rR0kXHIZ1Z

22 Nov 2019

Reply Repost Favourite

Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe #psoriasis: Results from Greater Than 17,000 Patient-Years of Exposure. You can read the full article here: https://t.co/vltv1EEG7Q #dermatology https://t.co/QxtDB6C

22 Nov 2019

Reply Repost Favourite